Skip to content

Lipoprotein(a) — Lp(a)

Also called Lp little a

An LDL-like particle with an added apolipoprotein(a) tail.

  • Lab price$32.50

Normal is not optimal

An independent, causal risk factor for heart attack, stroke and aortic stenosis that almost nobody tests.

Ranges
Standard
Same; levels run slightly higher in women and rise after menopause
Optimal
Same thresholds.

Check your own Lipoprotein(a) — Lp(a) number

Order it yourself

One test, drawn at a Quest lab near you. The price is the lab’s, from Marek’s own menu.

Lipoprotein(a) — Lp(a) test
Marek Diagnostics · single test, drawn at Quest
$32.50
Code CAMERON
Order this test

Code CAMERON takes 10% off. Marek’s checkout adds its one-time blood-draw fee to individual tests and shows the total before you pay.

Order it with ApoB (Apolipoprotein B) and Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) (3 tests, one cart)

What moves Lipoprotein(a) — Lp(a)

Genetic — inherited. Not caused by diet or lifestyle. Modestly increased by menopause, hypothyroidism and kidney disease.

If it’s high: Means every other risk factor — ApoB, blood pressure, insulin resistance, smoking — must be controlled more aggressively, because your baseline risk is already elevated.

If it’s low: Favorable; nothing to act on.

No peptide interaction. Purely a risk-stratification test.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Everything else about Lipoprotein(a) — Lp(a)

What can skew the result

2 things can change the reading or the real level

Some change your real level; others only change the reading. Each one says which, and what to do about it.

InflammationPhysiological state

Lp(a) is a modest acute-phase reactant and rises during inflammation, which is the main reason a repeat value differs from the first.

Do this: Measure when well. And you only need it once — it is genetically fixed.

A real change — retest once it passes
Units — mg/dL vs nmol/LAssay

Not a biological interference but the most common misreading of this marker. The two units are not interchangeable and there is no exact conversion, because the assay depends on particle size.

Do this: Use nmol/L where possible, and never compare a mg/dL result to an nmol/L threshold.

The number is wrong — repeat it

Symptoms it helps explain

3 symptoms, and which to test first

Test this first if you have

  • Heart disease or stroke runs in my family

Then worth checking for

  • Chest pain, palpitations or breathlessness
  • Blood clot, DVT, or clotting runs in my family

Plan of attack

What to do, in this order
  1. Confirm the number is real

    Units — mg/dL vs nmol/L. Not a biological interference but the most common misreading of this marker. The two units are not interchangeable and there is no exact conversion, because the assay depends on particle size. Use nmol/L where possible, and never compare a mg/dL result to an nmol/L threshold.

  2. Read it with its partner

    Draw it alongside: ApoB (Apolipoprotein B), Lipid Panel (Cholesterol, HDL, LDL, Triglycerides), hs-CRP (High-Sensitivity C-Reactive Protein).

  3. Work out which direction is yours

    If it's high — Means every other risk factor — ApoB, blood pressure, insulin resistance, smoking — must be controlled more aggressively, because your baseline risk is already elevated. It also strengthens the case for early imaging (coronary calcium score).

  4. Fix it in order: food, then cause, then everything else

    Nutrition. Diet barely moves Lp(a) — and that's not a failure, it's the biology. Don't chase it with food; control ApoB instead.
    Lifestyle. Since you can't lower it much, the play is aggressively managing everything you can control — blood pressure, ApoB, glucose, smoking, fitness.

  5. Retest

    Once in a lifetime is sufficient unless kidney or thyroid status changes markedly. Change one thing at a time, or the retest can't tell you which thing worked.

What Lipoprotein(a) — Lp(a) measures

And why people check it

What it tells you

An LDL-like particle with an added apolipoprotein(a) tail. Your level is roughly 90% genetically determined and essentially fixed for life.

Why people check it

An independent, causal risk factor for heart attack, stroke and aortic stenosis that almost nobody tests. Because it's genetic and stable, it only needs to be measured once in a lifetime — and every current guideline says to do exactly that.

What Lipoprotein(a) — Lp(a) means next to other markers

2 patterns worth knowing
The risk your lipid panel cannot see

Lp(a) elevated · ApoB high · Family history of early heart disease · Standard cholesterol "fine"

Lp(a) is almost entirely genetic, largely unmoved by diet, and independently raises cardiovascular and aortic valve risk. A normal LDL alongside it is falsely reassuring.

Measure it once — it barely changes over a lifetime. You cannot lower it much yet, so the response is to drive everything else down hard: ApoB, blood pressure, insulin resistance, smoking. Tell your first-degree relatives to test theirs.

A clotting picture assembling quietly

Fibrinogen high · D-dimer raised · Homocysteine high · Lp(a) elevated

Several independent contributors to clot risk stacking together. Each is unremarkable alone; the combination is not, particularly alongside androgen use, high hematocrit, estrogen therapy or long-haul travel.

A raised D-dimer with leg swelling, chest pain or breathlessness is an emergency, not a retest. Otherwise: address homocysteine with B12/folate/B6, treat the inflammation driving fibrinogen, and review anything estrogenic or androgenic you are taking with a clinician.

Panels that carry Lipoprotein(a) — Lp(a)

2 panels, prices with code CAMERON

Read it alongside

Related markers, goals and what moves it in the library

The deep read, with sources

What the Lipoprotein(a) — Lp(a) test actually measures, and the references

What Lipoprotein(a) — Lp(a) actually measures — the analyte, and the assay

The analyte is a particle, not a molecule: an LDL-like core carrying apolipoprotein B, with a second protein — apolipoprotein(a) — welded to it by a disulfide bond. Apo(a) is a plasminogen relative built from looped kringle domains, and one of those domains, kringle IV type 2, is present in a number of copies that varies from a handful to several dozen between people. Apo(a) therefore has no fixed size, ranging across hundreds of kilodaltons, and the number of repeats you inherited is inversely related to how much Lp(a) you circulate Volgman 2024.

That variable protein is why this test has two units that are not interchangeable. A mass assay reports mg/dL and measures the total protein present; if its antibody binds an epitope inside the repeated kringle, a person with a large isoform generates more signal per particle and reads high, while a small-isoform carrier reads low. A molar assay reports nmol/L and is designed to count particles regardless of size, which is what the risk actually tracks. Building an assay that genuinely does not care about isoform size is difficult enough to be a publishable achievement in its own right: an isoform-independent monoclonal ELISA validated over an analytical measuring range of 0.27–1,402 nmol/L, correlating at r = 0.987 and r = 0.976 with comparison methods Marcovina 2022.

There is no valid conversion factor between the two units, and this is where real results get misread. In 11,970 participants of a cardiovascular outcome trial, the same samples gave a median of 21.8 mg/dL on one test and 45.0 and 42.2 nmol/L on two molar tests Szarek 2023. That is a ratio near 2.1 in that cohort — not the 2.5 that circulates as a rule of thumb, and in any case a ratio that changes person by person with isoform size. Multiply your mg/dL by 2.5 and you can move yourself across a treatment threshold that nothing in your blood has crossed. The practical guidance is to ask for the molar result and never to convert Cegla 2021.

Within a single unit the assays are precise. Five commercial Lp(a) immunoassays run on one chemistry analyzer gave coefficients of variation of 2.5–5.2% on a low pool averaging 7.3–12.4 mg/dL and 0.8–3.0% on a high pool averaging 31.5–50.2 mg/dL Wyness 2021. Note what those numbers say: the five assays each measure reproducibly, and they do not agree with each other about the concentration — the low pool alone spanned 7.3 to 12.4 mg/dL depending on which one ran it.

Lipoprotein(a) — Lp(a): what changes the blood, and what only changes the reading

What changes the Lp(a) in your blood — and this is the shortest such list in the estate:

  1. The LPA gene you inherited. Between 80% and 90% of the between-person variation is genetic, set by kringle repeat number and by variants in and around the locus Volgman 2024 Kronenberg 2022. Nothing else on this list comes close.
  2. Ancestry, which is the population-level expression of the same genetics: median concentrations differ substantially between ancestral groups, so a threshold derived in one population is not automatically the right threshold in another Volgman 2024.
  3. Kidney function. Chronic kidney disease and especially nephrotic syndrome raise it, and the rise reverses if the kidney problem does.
  4. Thyroid status. Untreated hypothyroidism raises Lp(a) and replacement lowers it — one more reason the thyroid panel and the lipid panel are read together rather than separately.
  5. Estrogen. Concentrations rise after menopause and fall on estrogen therapy.
  6. Inflammation. Lp(a) behaves as a modest acute-phase reactant, so a value drawn in the weeks after a heart attack, an operation or a serious infection is not the baseline.
  7. Drugs. PCSK9 inhibitors and niacin lower it modestly; the RNA-targeted agents built specifically against apo(a) lower it far more and were still in outcome trials when the European consensus was written Kronenberg 2022. Statins do not lower it.

What changes only the reading — and here the list is longer than the biology:

  1. Mass versus molar reporting. The dominant term, and the reason two results a year apart can look like a change that never happened Szarek 2023.
  2. Isoform-dependent bias in any assay whose antibody sees the repeated kringle Marcovina 2022.
  3. Which of several commercial assays the laboratory bought Wyness 2021.
  4. A conversion applied by a website, an app or a clinician working from memory. This is not a laboratory error, and it is probably the commonest way a person ends up with the wrong Lp(a) in their head Cegla 2021.

Reference interval or decision threshold — which kind of number Lipoprotein(a) — Lp(a) is

This is a risk threshold pretending to be a reference interval, and the pretense does more harm here than anywhere else on the site. Lp(a) is not distributed like a normal laboratory analyte: the population distribution is steeply right-skewed, with a large fraction of people near the bottom of the scale and a long tail. A 'central 95%' of that shape is not a meaningful statement, and no laboratory's reference interval is doing the work people think it is.

What exists instead are concentrations above which measured event rates rise, derived from cohorts and genetic studies and set out in the European Atherosclerosis Society's consensus statement Kronenberg 2022. Those are decision thresholds in the strict sense, and — the point of the assay section above — they are quoted in molar units because that is the unit the risk was measured in. A threshold expressed in nmol/L cannot be applied to a result expressed in mg/dL without an isoform-dependent error Cegla 2021 Szarek 2023.

Risk is also continuous rather than switched. There is no concentration at which nothing happens below and something happens above; the thresholds are places on a slope chosen to be clinically actionable. Recent work has begun applying the same logic outside coronary disease, assessing apoB and Lp(a) for sex-specific aortic stenosis risk Shi 2026 — a disease with no lipid-lowering treatment at all, which is a useful reminder that a risk threshold is not automatically a treatment threshold.

How you would know your Lipoprotein(a) — Lp(a) was wrong — and when to redraw

Once, ever, for most people — and the reason is genetic rather than practical. Concentration is 80–90% determined by a locus you were born with Volgman 2024, it is stable from childhood, and it does not respond to diet, exercise or weight change. The consensus position is that a single measurement in a lifetime is enough to classify most adults Kronenberg 2022. That makes it the cheapest permanent piece of information on the whole panel.

Five circumstances genuinely justify a second measurement, and only these: the first result was reported in mg/dL and a molar assay is now available; it was drawn within weeks of a myocardial infarction, surgery or serious infection, when Lp(a) is transiently raised; new or worsening kidney disease; a change in thyroid status or the start of treatment for it; or starting, stopping or changing estrogen therapy.

What would have to change for the second value to mean anything. Given the genetics, a real change of any size demands an acquired explanation from that list. Everything else is method. Before believing that your Lp(a) has moved, confirm that both results are in the same unit, from the same assay, in the same clinical state — and if any of the three differs, the change is in the measurement Szarek 2023 Wyness 2021.

How you would know the value was wrong. An Lp(a) that 'improved' after a diet, a supplement or a period of training is the clearest possible signal of an assay or unit change, because none of those interventions has been shown to move it. The confirmatory step is to obtain the original report, read the unit, and ask which assay each laboratory ran Cegla 2021.

What Lipoprotein(a) — Lp(a) cannot tell you

It cannot tell you when, only whether. Lp(a) describes a lifelong exposure. It does not predict an event in a window, and a high value in a 30-year-old is a reason to control everything else aggressively for decades, not a forecast.

A low Lp(a) is not a clean bill of health. It removes one independent contributor and leaves apoB, blood pressure, glycemia and smoking exactly where they were.

It is already inside your LDL-C, and that distorts both numbers. Lp(a) particles carry cholesterol which the laboratory counts as LDL cholesterol. When Lp(a)-cholesterol was quantified directly it ranged from 0.6 to 35.0 mg/dL and accounted for anywhere between 5.8% and 57.3% of measured LDL-C; correcting for it moved mean LDL-C from 119.2 mg/dL to 102.2 mg/dL Yeang 2021. In someone with a high Lp(a), part of the 'LDL cholesterol' being treated belongs to a particle that statins barely touch.

Results in different units are not comparable and must not be trended — the single most consequential limitation on this page Szarek 2023.

The wrong inference readers actually draw is that a high Lp(a) is something to fix. As of the European consensus, the therapies capable of lowering it substantially were still in outcome trials and no lipid intervention had been shown to reduce events by lowering Lp(a) specifically Kronenberg 2022. What a high result changes is the aggressiveness with which everything modifiable is treated — and that is a real change, made on information you only have to buy once.

Sources read for these sections

  • Kronenberg F, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis. European Heart Journal 2022 · PMID 36036785
  • Cegla J, et al. Lp(a): When and how to measure it. Annals of Clinical Biochemistry 2021 · PMID 33040574
  • Szarek M, et al. Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests. Circulation 2023 · PMID 37632469
  • Marcovina SM, et al. Development and validation of an isoform-independent monoclonal antibody-based ELISA for measurement of lipoprotein(a). Journal of Lipid Research 2022 · PMID 35688187
  • Wyness SP, et al. Performance evaluation of five lipoprotein(a) immunoassays on the Roche cobas c501 chemistry analyzer. Practical Laboratory Medicine 2021 · PMID 33898688
  • Yeang C, et al. Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements. Journal of Lipid Research 2021 · PMID 33636163
  • Volgman AS, et al. Genetics and Pathophysiological Mechanisms of Lipoprotein(a)-Associated Cardiovascular Risk. Journal of the American Heart Association 2024 · PMID 38879448
  • Shi W, et al. Moving beyond Low-Density Lipoprotein cholesterol: apolipoprotein B and Lipoprotein (a) for sex-specific risk assessment of aortic stenosis in the UK Biobank. European Journal of Preventive Cardiology 2026 · PMID 42104638

Lipoprotein(a) — Lp(a) questions

6 answered
What is a normal Lipoprotein(a) — Lp(a) level?
Women: Same; levels run slightly higher in women and rise after menopause. Men: <75 nmol/L (or <30 mg/dL) reported as normal — risk is continuous. Ranges vary by laboratory and assay; always compare to the range printed on your own report.
What is the optimal Lipoprotein(a) — Lp(a) level?
Women: Same thresholds. Men: <75 nmol/L desirable. ≥125 nmol/L (~50 mg/dL) is a recognized risk-enhancing threshold (~1.4× ASCVD risk); 300–400 nmol/L approaches heterozygous familial hypercholesterolemia risk.
What does a high Lipoprotein(a) — Lp(a) mean?
Means every other risk factor — ApoB, blood pressure, insulin resistance, smoking — must be controlled more aggressively, because your baseline risk is already elevated. It also strengthens the case for early imaging (coronary calcium score).
What does a low Lipoprotein(a) — Lp(a) mean?
Favorable; nothing to act on.
How often should I retest Lipoprotein(a) — Lp(a)?
Once in a lifetime is sufficient unless kidney or thyroid status changes markedly.
How do I test Lipoprotein(a) — Lp(a)?
Through Marek Diagnostics without a doctor's visit, drawn at a Quest Diagnostics location in the US. Code CAMERON applies 10% off automatically through the links on this page.

Sources: 2026 AHA/ACC Dyslipidemia Guideline — measure at least once. Tsimikas S, J Am Coll Cardiol 2017 — Lp(a) as a causal risk factor.

Inside Skool · $10/mo

The Real Cardiovascular Risk protocol is a lesson in Skool

This page tells you what the number means and the order to act in. Skool is where it becomes a plan for your situation, read against your own labs.

  • The full Real Cardiovascular Risk protocol, step by step
  • Supplement form, timing and how long to run it
  • The hormones and compounds that move it, and what to watch
Join Skool $10/moCancel anytime

5.0 (15 reviews)1,500+ members

Coach Cam's community on Skool: the public page, with the rating, members and price

Want it built around you?

Educational and research purposes only. Not medical advice; talk to your clinician about results. Lab ranges vary by assay and laboratory: compare against the range printed on your own report. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer and affiliate disclosure

Order this testJoin Skool